These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22008100)

  • 21. Evidence for enhanced androgen action in the prefrontal cortex of people with bipolar disorder but not schizophrenia or major depressive disorder.
    Owens SJ; Purves-Tyson TD; Webster MJ; Shannon Weickert C
    Psychiatry Res; 2019 Oct; 280():112503. PubMed ID: 31446215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. State-dependent changes in the expression levels of NCAM-140 and L1 in the peripheral blood cells of bipolar disorders, but not in the major depressive disorders.
    Wakabayashi Y; Uchida S; Funato H; Matsubara T; Watanuki T; Otsuki K; Fujimoto M; Nishida A; Watanabe Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1199-205. PubMed ID: 18430502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of GABAA α2-, β1- and ε-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder.
    Fatemi SH; Folsom TD; Rooney RJ; Thuras PD
    Transl Psychiatry; 2013 Sep; 3(9):e303. PubMed ID: 24022508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.
    Kimoto S; Zaki MM; Bazmi HH; Lewis DA
    JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropathology markers and pathways associated with molecular targets for antipsychotic drugs in postmortem brain tissues: exploration of drug targets through the Stanley Neuropathology Integrative Database.
    Kim S; Zavitsanou K; Gurguis G; Webster MJ
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):683-94. PubMed ID: 22356822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis.
    Iwamoto K; Bundo M; Kato T
    Hum Mol Genet; 2005 Jan; 14(2):241-53. PubMed ID: 15563509
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder.
    Arion D; Corradi JP; Tang S; Datta D; Boothe F; He A; Cacace AM; Zaczek R; Albright CF; Tseng G; Lewis DA
    Mol Psychiatry; 2015 Nov; 20(11):1397-405. PubMed ID: 25560755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Post-mortem molecular profiling of three psychiatric disorders.
    Ramaker RC; Bowling KM; Lasseigne BN; Hagenauer MH; Hardigan AA; Davis NS; Gertz J; Cartagena PM; Walsh DM; Vawter MP; Jones EG; Schatzberg AF; Barchas JD; Watson SJ; Bunney BG; Akil H; Bunney WE; Li JZ; Cooper SJ; Myers RM
    Genome Med; 2017 Jul; 9(1):72. PubMed ID: 28754123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
    Tkachev D; Mimmack ML; Ryan MM; Wayland M; Freeman T; Jones PB; Starkey M; Webster MJ; Yolken RH; Bahn S
    Lancet; 2003 Sep; 362(9386):798-805. PubMed ID: 13678875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.
    Goldsmith DR; Rapaport MH; Miller BJ
    Mol Psychiatry; 2016 Dec; 21(12):1696-1709. PubMed ID: 26903267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
    Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
    J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. mRNA and protein expression for novel GABAA receptors θ and ρ2 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway.
    Fatemi SH; Folsom TD; Rooney RJ; Thuras PD
    Transl Psychiatry; 2013 Jun; 3(6):e271. PubMed ID: 23778581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of voltage-gated ion channels in mammalian brain.
    Trimmer JS; Rhodes KJ
    Annu Rev Physiol; 2004; 66():477-519. PubMed ID: 14977411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial-related gene expression changes are sensitive to agonal-pH state: implications for brain disorders.
    Vawter MP; Tomita H; Meng F; Bolstad B; Li J; Evans S; Choudary P; Atz M; Shao L; Neal C; Walsh DM; Burmeister M; Speed T; Myers R; Jones EG; Watson SJ; Akil H; Bunney WE
    Mol Psychiatry; 2006 Jul; 11(7):615, 663-79. PubMed ID: 16636682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of TrkB and BDNF transcripts in prefrontal cortex, hippocampus, and striatum from subjects with schizophrenia, bipolar disorder, and major depressive disorder.
    Reinhart V; Bove SE; Volfson D; Lewis DA; Kleiman RJ; Lanz TA
    Neurobiol Dis; 2015 May; 77():220-7. PubMed ID: 25796564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia.
    Pae CU; Chiesa A; Porcelli S; Han C; Patkar AA; Lee SJ; Park MH; Serretti A; De Ronchi D
    Neuropsychobiology; 2012; 65(1):1-11. PubMed ID: 22094229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders.
    Darby MM; Yolken RH; Sabunciyan S
    Transl Psychiatry; 2016 Sep; 6(9):e890. PubMed ID: 27622934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mitochondrial DNA 3243A>G mutation and increased expression of LARS2 gene in the brains of patients with bipolar disorder and schizophrenia.
    Munakata K; Iwamoto K; Bundo M; Kato T
    Biol Psychiatry; 2005 Mar; 57(5):525-32. PubMed ID: 15737668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased expression of inwardly rectifying Kir4.1 channel in the parietal cortex from patients with major depressive disorder.
    Xiong Z; Zhang K; Ren Q; Chang L; Chen J; Hashimoto K
    J Affect Disord; 2019 Feb; 245():265-269. PubMed ID: 30419525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide Y Y(1) and Y(2) receptor mRNA expression in the prefrontal cortex of psychiatric subjects. Relationship of Y(2) subtype to suicidal behavior.
    Caberlotto L; Hurd YL
    Neuropsychopharmacology; 2001 Jul; 25(1):91-7. PubMed ID: 11377922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.